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Introduction
Aortic valve diseases can cause dyspnoea, palpitations, syncope 
and anginal symptoms, and it can also lead significant low cardiac 
output and sudden death. In aortic stenosis, progressive left ven-
tricular outflow tract obstruction increases left ventricular systolic 
pressure. While increased left ventricular systolic pressure raises 
myocardial oxygen requirement, it also decreases oxygen delivery 
and causes subendocardial ischemia. In such patients, compensa-
tory left ventricular hypertrophy develops, and this causes diastol-
ic dysfunction and pulmonary congestion. Aortic valve diseases 
may require conventional or minimal invasive surgical methods 
along with repair or replacement in addition to medical treatment. 
While conventional median sternotomy provides a good surgical 
exposure, serious complications such as mediastinitis can effect 
directly to the survey. Compared to classic median sternotomy, 
aortic valve replacement via right anterior mini-thoracotomy 
bears such advantages as the preservation of  anatomical integrity, 
less bleeding and lower transfusion requirement, decreased stress 
response to surgery, lower respiratory complications, lowered 
complications of  wound healing, provision of  faster recovery, 
and related shortened hospital stays [2-9]. Minimal invasive heart 
surgery requires a unique anaesthesia method. It is important 
to establish functional deterioration due to aortic valve disease 
and accompanying comorbid conditions, and if  possible, to ap-
ply treatments that would provide their relief  during preopera-
tive preparations. During anaesthesia induction and maintenance, 
monitoring and application of  anaesthetic agents and other drugs 
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Abstract
Objective: Minimally invasive aortic valve replacement is a common procedures in practice. Our aim is to present our experi-
ences on our anaesthesia applications during these operations.
Methods: Upon the approval of  the Hospital Ethics Committee, data of  the patients that underwent minimal invasive aortic 
valve surgery between 1 January 2017 and 31 August 2017 were analysed retrospectively. Recorded details were age, gender, 
Body Mass Index (BMI), American Society of  Anesthesiologists (ASA) classification, New York Heart Association classification 
(NYHA), Ejection Fraction (EF), Euroscore II, smoking history, accompanying diseases, cardiopulmonary bypass duration, aor-
tic cross-clamping time, presence or absence of  ventricular fibrillation, number of  blood products given, time spent in intensive 
care unit, hospital stay, and intensive care mortality.
Results: Results from a total of  22 patients were analysed. Median value for age was 55, minimum was 36, and maximum was 
83. Of  the patients, 59% was female, while 41% was male. It was found that 68% of  the patients were classified as NYHA II 
and 32% fell into NYHA III. Euroscore II percentage was established as median 1.73 (minimum 0.79-maximum 2.75). Median 
cardiopulmonary bypass time was 120 minutes (minimum 73 minutes-maximum 165 minutes), and median cross-clamp time was 
95 minutes (minimum 47 minutes-maximum 127 minutes). Median length of  stay in intensive care unit was 15 hours (minimum 
8 hours-maximum 23 hours), median hospitalization duration was established as 5 days (minimum 3 days-maximum 9 days).
Conclusion: Anaesthesia applications in minimally invasive surgery carried out for aortic valve diseases predominantly include 
preoperative preparation, perioperative monitoring, and postoperative pain management.
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and replacement therapies in order to preserve the haemodynam-
ic stability require patient-specific attention. Single-lung ventila-
tion can be implemented in order to increase surgical view. Shunt-
increasing effects of  anaesthetic agents can be observed during 
one-lung ventilation. Desflurane blood-gas partition is a low coef-
ficient inhalation anaesthetic. It was shown to provide both early 
recovery and early discharge [10-12].
It is important to proctect myocardium which has been hyper-
trophied and dilated during cardiopulmonary bypass. For this 
reason, a suitable cardioplegia method should be selected. Del 
Nido cardioplegia solution is a cheap method that does not con-
tain glucose and calcium and that is mostly used as a single dose 
[13]. Postoperative pain characteristics are different in median 
sternotomy and anterior mini-thoracotomy, and various treatment 
approaches may be required [14-16]. 
In literature there are few studies which is about perioperative 
anaesthesia management during minimally invasive aortic valve 
surgery. Anaesthesiologists have a vital role in such a possibly 
complicated patient group. Our aim is to share our experiences 
on this issue and to review other studies published in the field.
Methods
This study was conducted at a tertiary care hospital upon the ap-
proval of  the Hospital Ethics Committee. Patients who under-
went aortic valve replacement via right anterior mini-thoracotomy 
in the Cardiovascular Surgery Clinic between 1 January 2017 and 
31 August 2017 were included in the study. Exclusion criteria were 
patients below the age of  18, patients who underwent median 
sternotomy, and patients without available records. Data of  the 
patients included in the study were analysed retrospectively from 
the hospital's electronic medical records system. Age, gender, 
BMI, ASA and NYHA classifications, EF, Euroscore II, smok-
ing history, accompanying diseases, cardiopulmonary bypass time, 
cross-clamp time, presence of  ventricular fibrillation, number of  
blood products received, intensive care unit length of  stay, hospi-
tal stay, and intensive care unit mortality were recorded.
As premedication, all patients were given 5mg diazepam 8 hours 
before the operation orally. Thirty minutes before the surgery, 
0.1mg/kg morphine was administered intramuscularly. Patient 
taken to the operation room underwent, six-channel ECG, pulse 
oximetre, invasive arterial blood pressure, central venous pres-
sure measurement through jugular central vein catheterisation, 
bispectral index, and Near-Infrared Spectroscopy (NIRS). Exter-
nal defibrillator pads were appropriately placed on the back of  
patients. Following the anaesthesia induction with 0.04mg/kg 
midazolam, 10mcg/kg fentanyl, 1mg/kg propofol, and 0.5mg/kg 
rocuronium, endobronchial intubation was conducted with left 
double-lumen tube. Correct placement of  double-lumen tube was 
provided with auscultation. Controlled ventilation was ensured in 
manner suitable for each patient so as to provide end-tidal carbon 
dioxide within normal limits. Anaesthesia was maintained with 
2-6% desflurane, 50% oxygen and 50% air mix. Rocuronium and 
fentanyl were administered every 45 minutes as intravenous bo-
lus. Through right internal jugular vein, central venous catheter 
and oral transoesophageal echocardiography (TEE) probe were 
placed. Patient was given 30 degree left lateral decubitus position. 
Following suitable surgical area cleaning and surgical covering, 
low-dose heparinisation was carried out. Femoral artery and vein 
were cannulised. Using double-lumen tube, right lung ventila-
tion was stopped and only the left lung ventilation was permit-
ted. Right lung was deflated and right anterior mini-thoracotomy 
incision of  4-5cm was conducted. Heparinisation of  300 IU.kg-1 
dosage was carried out with activity clotting time being lower than 
400 seconds. Cardiopulmonary bypass was conducted by using 
roller pump and with 2.4L.m2.min-1 non-pulsatile current. During 
cardiopulmonary bypass, systemic hypothermia was maintained 
at 30-32°C. After aortic cross-clamp was placed, cardia arrest was 
conducted Del Nido cardioplegia solution was administered via 
antegrade approach for the myocardial protection. Following the 
replacement of  prosthetic valve, deairing was done with the help 
of  TEE. Patient temperatures were increased to 37°C after the 
removal of  cross-clamp. Patients who developed ventricular fi-
brillation were defibrillated with the help of  external pads. Af-
ter establishing haemodynamic stability, patients were separated 
from cardiopulmonary bypass. Protamine was administered after 
decanulation. When surgical procedure was completed, double-
lumen tube and TEE probe were removed. Patient was then intu-
bated with single-lumen endotracheal tube. In order to contribute 
to postoperative analgesia, 20 ml 0.25% bupivacaine was injected 
in the wound site and its periphery in thoracotomy site. Follow-
ing surgery, patients were transferred to cardiopulmonary surgery 
intensive care unit in a motorised matter. During the post-opera-
tive period, multimodal analgesia was ensured with paracetamol, 
tramadol, and diclofenac.
Statistical Analysis
All analyses were carried out by using SPSS (version 21.0) soft-
ware. Categorical variables in patients were expressed by numbers 
and percentage. Whether the distribution of  numerical data was 
normal or not was evaluated by histogram analysis. Results that 
did not manifest normal distribution were expressed by median 
value, minimum and maximum.
Results
Aortic valve replacement via right anterior mini-thoracotomy was 
conducted on a total of  22 patients within eight months between 
1 January 2017 and 31 August 2017. Table 1 shows demographic 
and clinical data of  these patients. Median value of  age was 55 
with minimum being 36 and maximum 83. Of  the patients, 59% 
were female and 41% were male. Functional status of  68% of  
patients were NYHA II and in 32% of  them were in NYHA III. 
Euroscore II percentage was found as median 1.73 (minimum 
0.79-maximum 2.75). Of  the patients, 41% had smoking history. 
Among the accompanying diseases, the most common ones were 
established as hypertension (41%) and diabetes mellitus (41%).
Median cardiopulmonary bypass time was 120 minutes (minimum 
73 minutes-maximum 165 minutes) and median cross-clamp time 
was 95 minutes (minimum 47 minutes-maximum 127 minutes). 
Ventricular fibrillation occurred in 27% of  these patients,. While 
median length of  stay in intensive care unit was established as 15 
hours (minimum 8 hours-maximum 23 hours), median hospitali-
zation duration was 5 days (minimum 3 days-maximum 9 days) 
(Table 2). All patients were administered a total of  18 units of  
erythrocyte suspension and 20 units of  fresh frozen plasma. In-
tensive care unit mortality rate of  patients included in the study 
was 9%.
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Discussion
We found the intensive care unit mortality rate in patients that 
underwent aortic valve replacement via right anterior mini-
thoracotomy as 2%. Minimal invasive techniques have become 
widespread in recent years in the field of  surgery. Aortic valve re-
placement via right anterior mini-thoracotomy conducted in our 
country in a few centres fall into the category of  minimal invasive 
procedures. Since minimal invasive heart surgery techniques are 
different from conventional techniques, there are certain issues 
that anaesthesiologists need to consider. In addition to clinical 
conditions of  aortic valve patients being critical, anaesthesia and 
surgical operation bear additional risks. 
Anaesthesiologists need to evaluate complaints, symptoms, and 
physical examination findings due to both aortic valve pathology 
and accompanying diseases of  the patient by conducting preop-
erative patient visits. Single-lung ventilation provides a better sur-
gical view in aortic valve replacement surgeries by right anterior 
mini-thoracotomy compared to double-lung ventilation. In an 
observational study conducted on 187 patients, Stolinski et al., 
compared the effects of  single-lung and double-lung ventilations 
on respiratory functions during aortic valve replacement surgery 
by right anterior mini-thoracotomy. They observed that single-
lung ventilation and double-lung ventilation did not pose signifi-
cant differences in terms of  respiratory functions [17]. A decision 
should be made for patients that are to undergo heart surgery 
by mini-thoracotomy on whether they would tolerate single-lung 
ventilation by analysing pulmonary function tests, arterial blood 
gas, and postero-anterior pulmonary roentgenography in the 
preoperative period [1, 14]. A prolonged single-lung ventilation 
may not be maintained in patients with such pathologies as active 
bronchospasm or bullous lungs. Single-lung ventilation may cause 
an increase in the pulmonary artery pressure, decreased cardiac 
output, hypoxia and hypercarbia [18]. It is of  utmost importance 
to bring the respiratory functions to the optimal level before op-
erating on these patients. Of  our patients that had severe chronic 
pulmonary disease received medical treatment in the preopera-
tive period to recover respiratory functions by consulting chest 
disease specialists. Smoking should be quit as soon as possible. It 
bears importance to stop smoking at least two weeks before the 
surgery in order to decrease perioperative complications [14]. 
A low-dose oral benzodiazepine is recommended a night before 
the surgery as premedication in patients being prepared for mini-
mal invasive open-heart surgery [14]. In addition, administration 
of  intramuscular morphine half  an hour before the operation 
would lead to patient being calmer and vital findings being stable 
[19].
In preoperative cardiovascular evaluation of  patients with aortic 
valve disease, functional condition of  the heart should be estab-
lished through obtaining the history, physical examination, and 
invasive and non-invasive techniques. Among the non-invasive 
techniques are Holter ECG and echocardiography. Cardiac cath-
eterisation is among invasive techniques. Severe aortic stenosis is 
known by mean pressure gradient being higher than 40 mmHg, 
and aortic valve site being under 1cm2 or being symptomatic [20]. 
Perioperative monitoring bears utmost importance in terms of  
establishing cardiac complications in aortic valve operations. Use 
of  TEE is quite beneficial in aortic valve surgery that utilises in-
Table 1. Demographic and clinical data of  patients.
Age (Years) 55(36-83)




Ejection fraction (%), EF=30-50%/EF > 50% 10(45%)/12(55%)
Euroscore II (%) 1.73(0.79-2.75)
Smoking history 9(41%)




Chronic Obstructive Pulmonary Disease 4(18%)
Chronic renal disease 1(5%)
Values are given as median (minimum-maximum) and in numbers (%).
Table 2. Perioperative data of  patients that underwent aortic valve replacement surgery by right anterior mini-thoracotomy.
Cardiopulmonary bypass time (minutes) 120(73-165)
Cross-clamp time (minutes) 95(47-127)
Ventricular fibrillation 6(27%)
ICU length of  stay (hours) 15(8-23)
Hospital stay (days) 5(3-9)
Transfused erythrocyte suspension (n) 18
Transfused fresh frozen plasma (n) 20
Intensive care unit mortality (n) 2(9%)
Values are given as median (minimum-maximum) and in numbers (%).
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vasive techniques. Owing to TEE, removal of  air also known as 
deairing is ensured in addition to the evaluation of  myocardial 
ischemia, heart wall abnormalities, left ventricular diastolic func-
tions, condition of  volume, and catecholamine treatment [21-23]. 
Compared to other haemodynamic monitoring methods, the ad-
vantages of  TEE include its ability to place and apply in a short 
time. However, it has such disadvantages as inability to provide 
constant monitoring, expensiveness, dependent on operator train-
ing, and the risk of  gastrointestinal perforation [24, 25]. 
Pulmonary artery catheter may be utilised for cardiac surgery in 
patients with high risk that requires establishing cardiac output 
syndrome, pulmonary hypertension, and right and left ventricular 
dysfunction. However, it is not recommended for patients with 
low perioperative risk [26-30]. Such minimally invasive cardiac 
output measurement methods such as transpulmonary thermodi-
lution and pulse contour analysis are alternatives to pulmonary 
artery catheterisation [31-33]. In minimally invasive cardiac sur-
gery, further studies are needed to establish the results in patients 
that receive such haemodynamic measurement methods that are 
less invasive.
Following anaesthesia induction, anaesthesia can be maintained 
with volatile inhalation agents. Volatile inhalation agents were 
found to decrease postoperative troponin I levels in patients that 
undergo cardiac surgery [34-36]. Of  the inhalation agents, desflu-
rane was shown to provide a decrease in markers of  myocardial 
necrosis and recovery of  postoperative myocardial functions [37]. 
Durign aortic valve surgery, myocardial damage that may occur 
during aortic cross-clamp can be prevented by cardioplegia meth-
ods. Del Nido cardioplegia solution was suggested to increase tol-
erance against intracellular calcium increase that causes irrevers-
ible myocyte damage and to provide sufficient protection with a 
single dose through uniform distribution in myocardium [38-43]. 
When compared to other conventional cardioplegia methods in 
some studies, aortic cross-clamp time was found as shorter in pa-
tients that receive Del Nido cardioplegia [44, 45]. In contrast, in 
a study by Vistarini et al., Del Nido cardioplegia was shown not 
to shorten aortic cross-clamp time [46]. In our study, all patients 
were administered Del Nido cardioplegia. Both ease of  applica-
tion and uninterrupted surgery along with lower costs were en-
sured this way by administering only a single dose of  cardioplegia.
Minimally invasive surgery bears such advantages as less blood 
transfusion, better pulmonary functions, shorter hospital stays, 
and smaller skin scars from a cosmetic point of  view compared 
to conventional heart surgery [47-55]. 
Postoperative pain management is quite important following 
heart surgery since pain causes tachycardia and hyperventilation. 
Occurrence of  hypoxia during the period of  heightened myo-
cardial oxygen demand exacerbates the clinical picture of  patient 
[14]. Multimodal analgesia is a recommended method in recent 
years for postoperative pain management. A well pain manage-
ment ensures early mobilisation and fast recovery [56].
Conclusion
In minimally invasive surgery conducted for aortic valve diseases, 
anaesthesiologists should carefully complete preoperative prepa-
ration. Technical equipment suitable for perioperative monitoring 
should be used and anaesthesia applications should be specific to 
this operation should be carried out.
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